Anticholinergic poisoning with adulterated intranasal cocaine

American Journal of Emergency Medicine

Volumn 16, Issue 5, 1998, Pages 517-520

  Weiner, Alan L ^a,b   Bayer, Marc J ^a   McKay Jr , Charles A ^a,b   DeMeo, Margaret ^a   Starr, Elizabeth ^a  

^a Department of Medical Toxicology   (United States)

^b HARTFORD HOSPITAL   (United States)

Author keywords

Adulterants; Anticholinergic poisoning; Cocaine; Physostigmine

Indexed keywords

ACTIVATED CARBON; COCAINE; LORAZEPAM; PHYSOSTIGMINE;

ADULT; AGITATION; ANTICHOLINERGIC EFFECT; ARTICLE; CASE REPORT; DRUG ABUSE; DRUG INTOXICATION; DRUG URINE LEVEL; HUMAN; ILEUS; INTRAVENOUS DRUG ADMINISTRATION; MALE; MYDRIASIS; PRIORITY JOURNAL; SUBSTANCE ABUSE; SYMPTOMATOLOGY; TACHYCARDIA;

EID: 0031880999     PISSN: 07356757     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-6757(98)90007-9     Document Type: Article

References (22)

1. 1995 Preliminary Estimates of Drug Related Emergency Department Episodes (ed 10): Rockville, MD, US Department of Health and Human Services, 1996, pp 32-40
2. Shesser R, Jotte R, Olshaker J: The contribution of impurities to the acute morbidity of illegal drug use. Am J Emerg Med 1991;9:336-342
3. Schauben JL: Adulterants and substitutes. Emerg Med Clin North Am 1990;8:595-610
4. Shannon M: Clinical toxicity of cocaine adulterants. Ann Emerg Med 1988;17:1243-1247
5. Lombard J, Levi IH, Weiner WJ: Arsenic intoxication in a cocaine abuser. N Engl J Med 1989;320:869
6. Insley BM: Thallium poisoning in cocaine users. Am J Emerg Med 1986;4:545-547
7. Centers for Disease Control: Scopolamine poisoning among heroin users. MMWR Morbid Mortal Wkly Rep 1996;45:457-461
8. Gomez J, Rodriguez A: An evaluation of the results of a drug sample analysis. Bull Narcotics 1989;41:121-126
9. Ellenhorn MJ: Ellenhorn's Medical Toxicology. Baltimore, MD, Williams & Wilkins, 1997
10. Moffat AC: Thin layer chromatography. In Moffat AC (ed): Clarke's Isolation and Identification of drugs. London, Pharmaceutical Press, 1986, pp 160-267
11. Ali-Melkkila T: Pharmacokinetics of anticholinergic drugs. Acta Anesthesiol Scand 1993;37:633-670
12. Quandt CM, Sommi RW, Pipkin T, et al: Differentiation of cocaine toxicity: Role of the toxicology drug screen. Drug Intell Clin Pharm 1988;22:582-588
13. Nogue S, Sanz P, Munne P: Acute scopolamine poisoning after sniffing adulterated cocaine. Drug Alcohol Dependence 1991;27: 115-116
14. Weisman RS, Goldfrank LR: Antihistamines. In Goldfrank LR, Flomenbaum NE, Lewin NA, et al (eds): Goldfrank's Toxicologic Emergencies (ed 5). Norwalk, CT, Appleton and Lange, 1994, pp 601-608
15. Johnson DW, Gunn AF, Gunn JW: Dangerous drugs: Adulterants, diluents and deception in street samples. J Forensic Sci 1972;17:629-633
16. Lewin NA, Goldfrank LR, Hoffman RS: Cocaine. In Goldfrank LR, Flomenbaum NE, Lewin NA, et al (eds): Goldfrank's Toxicologic Emergencies (ed 5). Norwalk, CT, Appleton and Lange, 1994, pp 847-862
17. Sarnquist F, Larson CP: Drug induced heatstroke. Anesthesiology 1973;39:348-352
18. Lewin NA: Physostigmine salicylate. In Goldfrank LR, Flomenbaum NE, Lewin NA, et al (eds): Goldfrank's Toxicologic Emergencies (ed 5). Norwalk, CT, Appleton & Lange, 1994, pp 607-608
19. Lapan D, Smith JW: Atropine coma: Physostigmine reversal. Ariz Med 1977;34:159-161
20. Greenblatt DJ, Shader RI: Atropine overdose in three children. Br J Anesth 1972;44:750-752
21. Burks JS, Walker JE: Tricyclic antidepresant poisoning. JAMA 1974;230:1405-1408
22. Vance MA, Ross SM, Millington WR: Potentiation of tricyclic antidepressant toxicity by physostigmine. Clin Tox 1977;11:413-416